← All trials
NCT02932306
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 29, 2015
- Primary completion
- Feb 14, 2017
- Completion date
- Mar 20, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 820
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Bausch Health CompaniesLead sponsor
- TKL ResearchStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.